首頁 > 市場調查報告書 > 製藥

疫苗感染疾病

到 2030 年北美瘧疾治療市場預測 - 區域分析 - 按治療、給藥途徑和配銷通路

市場調查報告書

商品編碼

1510755

到 2030 年北美瘧疾治療市場預測 - 區域分析 - 按治療、給藥途徑和配銷通路

North America Malaria Treatment Market Forecast to 2030 - Regional Analysis - by Treatment, Route of Administration, and Distribution Channel

出版日期: 2024年05月07日 | 出版商:

The Insight Partners | 英文 84 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2022年北美瘧疾治療市場估值為6,297萬美元，預計2030年將達4.8731億美元；預計2022年至2030年複合年成長率為29.1%。

瘧疾盛行率的增加推動了北美瘧疾治療市場

瘧疾是一種急性發燒性疾病，由瘧原蟲引起，並透過受感染的雌性瘧蚊傳播。人類體內的五種寄生蟲主要引起瘧疾，其中兩種——惡性瘧原蟲和間日瘧原蟲——被認為對人類健康構成最大威脅。此外，惡性瘧原蟲是最致命的瘧疾寄生蟲，在非洲大陸傳播最廣。此外，間日瘧原蟲是撒哈拉以南非洲以外大多數國家的主要瘧疾寄生蟲。根據世界衛生組織 (WHO) 最新發布的《2020 年世界瘧疾報告》(WMR)，全球報告了 2.41 億例瘧疾病例，而 2019 年記錄的病例數為 2.27 億例。人。其中約三分之二（即 47,000 人）是由於 COVID-19 爆發期間醫療服務中斷造成的；其餘三分之一的死亡人數，即 22,000 人，反映了世界衛生組織計算瘧疾死亡率的方法最近發生的變化（不考慮 COVID-19 的干擾）。因此，瘧疾盛行率的上升促進了瘧疾治療市場的成長。

北美瘧疾治療市場概況

根據美國疾病管制與預防中心 (CDC) 的數據，美國每年報告約 2,000 例瘧疾病例，其中大部分是來自其他國家的旅客和移民。孕婦和 5 歲以下兒童感染瘧疾和嚴重疾病的風險最高。由於能夠在美國傳播瘧疾的按蚊（媒介）的耐力，瘧疾傳播可能在美國恢復的永久風險。根據全球基金 2022 年 4 月的資料，與瘧疾相關的病例和死亡人數上升，主要是由於資金停滯和 COVID-19 大流行造成的干擾。然而，正如2022 年9 月全球基金報告中所提到的那樣，減輕這些影響的努力已取得進展。由美國全球瘧疾委員會監督協調員。根據全球衛生政策，2022 財政年度美國用於瘧疾控制和研究活動的資金約為 10 億美元。長期目標。

因此，美國瘧疾治療市場的成長是由瘧疾患者數量的增加所推動的。

北美瘧疾治療市場收入及 2030 年預測（百萬美元）

北美瘧疾治療市場細分

北美瘧疾治療市場根據治療、給藥途徑、配銷通路和國家進行細分。根據治療方法，北美瘧疾治療市場分為學名藥、原廠藥、疫苗等。 2022 年，疫苗領域佔據最大的市場。

就給藥途徑而言，北美瘧疾治療市場分為口服和腸外給藥。 2022年，口腔細分市場佔據了更大的市場。

依配銷通路，北美瘧疾治療市場分為直接招標、醫院藥局、零售藥局、線上藥局等。 2022 年，直接招標領域佔據最大的市場佔有率。

依國家/地區分類，北美瘧疾治療市場分為美國、加拿大和墨西哥。 2022年，美國在北美瘧疾治療市場佔有率中佔據主導地位。

Cipla Ltd、Sun Pharmaceutical Industries Ltd、賽諾菲 SA、GSK Plc、諾華 AG、輝瑞 Inc、AdvaCare Pharma USA LLC、VLP Therapeutics LLC 和 Lupin Ltd 是北美瘧疾治療市場的一些領先參與者。

Malaria, one of the acute febrile illnesses, is caused by plasmodium parasites and spreads through the infected female Anopheles mosquitoes. Five parasite species in humans mainly cause malaria, and two of these species-Plasmodium falciparum and P. vivax-are considered the greatest threat to human health. Also, P. falciparum is the deadliest malarial parasite, and it is most widely spread across the African continent. Further, P. vivax is the dominant malarial parasite in most countries outside of sub-Saharan Africa. According to the latest World Malaria Report (WMR) 2020 from the World Health Organization (WHO), 241 million cases of malaria were reported in the world, in comparison to 227 million cases that were logged in 2019. According to the same source, the number of deaths caused due to malaria has an annual rise of 69,000 deaths. Approximately two-thirds of these deaths, i.e., 47,000, were caused by disruptions in healthcare services during the COVID-19 outbreak; the remaining one-third of deaths, i.e., 22,000 reflected a recent change in the WHO's methodology for calculating malaria mortality (irrespective of COVID-19 disruptions). Thus, the rising prevalence of malaria boosts the malaria treatment market growth.

North America Malaria Treatment Market Overview

According to the Centers for Disease Control and Prevention (CDC), approximately 2,000 cases of malaria are reported annually in the US, mostly in travelers from other countries and immigrants. Pregnant women and children under 5 years of age are at the highest risk of contracting malaria and developing severe diseases. There is a perpetual risk that malaria transmission can resume in the US due to the endurance of anopheles mosquitoes (vectors) capable of transmitting malaria in the US. According to the Global Fund data from April 2022, cases and deaths related to malaria rose mainly due to stalled funding and disruptions caused by the COVID-19 pandemic. However, efforts to moderate these impacts have seen progress, as mentioned in the Global Fund report in September 2022. Efforts taken by the US government to control malaria include activities primarily through the US President's Malaria Initiative (PMI), overseen by the US Global Malaria Coordinator. According to Global Health Policy, US funding for malaria control and research activities was approximately US$ 1 billion in FY 2022. The US government's goal under the PMI Strategy 2021-2026 is to work and reduce deaths caused by malaria and decrease malaria morbidity, in turn approaching its long-term goal of elimination.

Thus, the malaria treatment market growth in the US is driven by the rising number of malaria patients.

North America Malaria Treatment Market Revenue and Forecast to 2030 (US$ Million)

North America Malaria Treatment Market Segmentation

The North America malaria treatment market is segmented based on treatment, route of administration, distribution channel, and country. Based on treatment, the North America malaria treatment market is segmented into generic drugs, originators, vaccines, and others. The vaccines segment held the largest market share in 2022.

In terms of route of administration, the North America malaria treatment market is bifurcated into oral and parenteral. The oral segment held a larger market share in 2022.

By distribution channel, the North America malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment held the largest market share in 2022.

Based on country, the North America malaria treatment market is segmented into the US, Canada, and Mexico. The US dominated the North America malaria treatment market share in 2022.

Cipla Ltd, Sun Pharmaceutical Industries Ltd, Sanofi SA, GSK Plc, Novartis AG, Pfizer Inc, AdvaCare Pharma USA LLC, VLP Therapeutics LLC, and Lupin Ltd are some of the leading players operating in the North America malaria treatment market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights - Malaria

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Malaria Treatment Market - Key Industry Dynamics

4.1 Key Market Drivers:
- 4.1.1 Increasing Prevalence of Malaria
- 4.1.2 Rising Initiatives to Raise Awareness about Malaria
4.2 Market Restraints
- 4.2.1 Availability of Counterfeit Antimalarial Drugs Followed by Subsequent Drug Resistance
4.3 Market Opportunities
- 4.3.1 Growing Strategic Initiatives by Market Players
4.4 Future Trends
- 4.4.1 Extending Pipeline of New Drugs and Vaccines
4.5 Impact Analysis

5. Malaria Treatment Market - North America Market Analysis

5.1 North America Malaria Treatment Market Revenue (US$ million), 2022 - 2030

6. North America Malaria Treatment Market - Revenue and Forecast to 2030 - by Treatment

6.1 Overview
6.2 North America Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
6.3 Vaccines
- 6.3.1 Overview
- 6.3.2 Vaccines Market Revenue and Forecast to 2030 (US$ Mn)
6.4 Generic Drugs
- 6.4.1 Overview
- 6.4.2 Generic Drugs Market Revenue and Forecast to 2030 (US$ Mn)
6.5 Originators
- 6.5.1 Overview
- 6.5.2 Originators Market Revenue and Forecast to 2030 (US$ Mn)
6.6 Others
- 6.6.1 Overview
- 6.6.2 Others Market Revenue and Forecast to 2030 (US$ Mn)

7. North America Malaria Treatment Market - Revenue and Forecast to 2030 - by Route of Administration

7.1 Overview
7.2 North America Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
7.3 Oral
- 7.3.1 Overview
- 7.3.2 Oral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Parenteral
- 7.4.1 Overview
- 7.4.2 Parenteral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Malaria Treatment Market - Revenue and Forecast to 2030 - by Distribution Channel

8.1 Overview
8.2 North America Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
8.3 Direct Tender
- 8.3.1 Overview
- 8.3.2 Direct Tender: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Hospital Pharmacies
- 8.4.1 Overview
- 8.4.2 Hospital Pharmacies: Malaria Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Retail Pharmacies
- 8.5.1 Overview
- 8.5.2 Retail Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Online Pharmacies
- 8.6.1 Overview
- 8.6.2 Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Malaria Treatment Market - Country Analysis

9.1 North America Malaria Treatment Market, Revenue and Forecast To 2030
- 9.1.1 Overview
  - 9.1.1.1 North America: Malaria Treatment Market, by Country
  - 9.1.1.2 US
  - 9.1.1.3 Overview
    - 9.1.1.3.1 US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.3.2 US: Malaria Treatment Market, by Treatment
    - 9.1.1.3.3 US: Malaria -Malaria Treatment Market, by Route of Administration
    - 9.1.1.3.4 US: Malaria Treatment Market, by Distribution Channel
    - 9.1.1.3.4.1 US: Malaria Treatment Market, by Hospital Pharmacies
    - 9.1.1.3.4.2 US: Malaria Treatment Market, by Retail Pharmacies
  - 9.1.1.4 Canada
  - 9.1.1.5 Overview
    - 9.1.1.5.1 Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.5.2 Canada: Malaria Treatment Market, by Treatment
    - 9.1.1.5.3 Canada: Malaria -Malaria Treatment Market, by Route of Administration
    - 9.1.1.5.4 Canada: Malaria Treatment Market, by Distribution Channel
    - 9.1.1.5.4.1 Canada: Malaria Treatment Market, by Hospital Pharmacies
    - 9.1.1.5.4.2 Canada: Malaria Treatment Market, by Retail Pharmacies
  - 9.1.1.6 Mexico
  - 9.1.1.7 Overview
    - 9.1.1.7.1 Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.7.2 Mexico: Malaria Treatment Market, by Treatment
    - 9.1.1.7.3 Mexico: Malaria -Malaria Treatment Market, by Route of Administration
    - 9.1.1.7.4 Mexico: Malaria Treatment Market, by Distribution Channel
    - 9.1.1.7.4.1 Mexico: Malaria Treatment Market, by Hospital Pharmacies
    - 9.1.1.7.4.2 Mexico: Malaria Treatment Market, by Retail Pharmacies

10. Malaria Treatment Market Industry Landscape

10.1 Overview
10.2 Growth Strategies in the Malaria Treatment Market
10.3 Inorganic Growth Strategies
- 10.3.1 Overview
10.4 Organic Growth Strategies
- 10.4.1 Overview

11. Company Profiles

11.1 Cipla Ltd
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Sun Pharmaceutical Industries Ltd
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Sanofi SA
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 GSK Plc
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Novartis AG
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Pfizer Inc
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Service
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 AdvaCare Pharma USA LLC
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 VLP Therapeutics LLC
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 Lupin Ltd
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments

12. Appendix

12.1 About Us
12.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Malaria Treatment Market Segmentation
Table 2. Malaria Drugs/Vaccine/Compounds Under Clinical Development
Table 3. Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
Table 4. Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Retail Pharmacies
Table 5. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 6. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 7. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 8. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 9. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 10. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 11. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 12. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 13. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 14. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 15. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 16. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 17. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 18. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 19. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 20. Recent Inorganic Growth Strategies in the Malaria Treatment Market
Table 21. Recent Organic Growth Strategies in the Malaria Treatment Market
Table 22. Glossary of Terms, Malaria Treatment Market

List Of Figures

Figure 1. Malaria Treatment Market - Key Industry Dynamics
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. North America Malaria Treatment Market Revenue (US$ million), 2022 - 2030
Figure 4. North America Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
Figure 5. Vaccines Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 6. Generic Drugs Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 7. Originators Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 8. Others Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 9. North America Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
Figure 10. Oral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Parenteral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. North America Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 13. Direct Tender: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Hospital Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Retail Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. North America Malaria Treatment Market, By Country, 2022 ($Mn)
Figure 19. North America: Malaria Treatment Market, By Key Countries, 2022 and 2030 (%)
Figure 20. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 21. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 22. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 23. Growth Strategies in the Malaria Treatment Market